Abstract:RECLASSIFICATION of the syndromes of cerebral degeneration in childhood is being impelled by rapidly expanding interest in pediatric neurology, by the emergence of medical genetics, and by specific discoveries in neurochemistry. The resounding eponyms for these syndromes, such as Pelizaeus-Merzbacher, Bielschowski, Spielmeyer-Vogt disease, and the like, are yielding to more logical and appropriate desgnations. Characteristic genetic patterns have been disclosed that introduce some order into this nosologic chaos and also provide a firmer basis for counseling parents of the d i e t e d child. Considerably more collation of data is required in this neglected field before inferences useful to the clinician can be offered. At present, the onset of progressive deterioration and neurologic defects in a previously healthy child poses a perplexing diagnostic problem. The pediatrician or neurologist is often skeptical of the mother’s story that the child was healthy at birth and developed normally. Rather, the conclusion often is erroneously made that a pre-existing birth injury became manifest as the child grew older. A greater awareness that regression due to progressive degenerative disease can occur might increase the frequency with which these conditions are diagnosed and reported, and greater familiarity with these syndromes might motivate more clinicians to pursue the study of the individual case to a finite etiologic diagnosis. The semeiology of this group is more or less uniform. In addition to the history of truncated development or regression and frequently of epileptic attacks, the neurologic examination reveals mental retardation, pyramidal tract signs, and often visual impairment with optic atrophy. Refinement of the diagnosis is dependent largely on laboratory studies. A sequential program of tests is offered, beginning with the simplest, that is, the urinalysis which would identify or exclude the following: 1) Galactosemia, in which the reducing substance in the urine, if present, is tested further for galactose. 2) Phenyl pyruvic oligophrenia; a green color with acidified ferric chloride is commonly pathognomonic. 3) Cytomegalic inclusion disease, which may be diagnosed by finding desquamated renal tubule cells containing nuclear or cytoplasmic inclusions. 4) Metachromatic type of diffuse sclerosis; red metachromatic granules can be demonstrated in the urine sediment stained with aqueous toluidine blue. Roentgenographic examination of the skull would further identify: 1) Cytomegalic inclusion disease, which often reveals fine punctate calcifications in the position around the lateral ventricles. 2) Toxoplasmosis, with more diffuse parenchymatous calcification. Skin and dye test would confirm the diagnosis. The electroencephalogram is of value in the diagnosis and particularly in prognosis. Hypsarhythmia, a fairly common finding in this group, presages progression, deterioration, and also difEculty in controlling the seizures. Alternating sleep spindles are associated with hydrocephalus, and focal abnormalities may suggest proencephaly or other cerebral malformations. The pneumoencephalogram would exclude certain congenital malformations and would reveal cerebral atrophy or hydrocephalus. Brain biopsy, a final diagnostic measure, is reserved for a few selective cases but may

XIV Frequency Modulated Tone Thresholds in Normal and Abnormally Adapting Ears

Towards a Sustainable Ocean Ecosystem: Innovations in Plastic Pollution Mitigation, Policy Collaborations, and Technological Advancements

Coastal microplastic pollution: Understanding coastal community stakeholder perceptions and resolution priorities

Progressive cerebral degenerations of childhood

Using systems mapping to understand the constraints and enablers of solutions to plastic pollution

Früherkennung von Lungenkrebs

The Marine Plastic Litter Issue: A Social-Economic Analysis

What Do We Know About Plastic Pollution in Coastal/Marine Tourism? Documenting Its Present Research Status from 1999 to 2022

An imperative to focus the plastic pollution problem on place-based solutions

TORPP - Turtles, One Health Research & Plastic Pollution: A multidisciplinary consortium to evaluate the environmental and health impact of Micro/NanoPlastics (MNPs) pollution

Plastic Debris in the Marine Environment: History and Future Challenges

Addressing marine plastic pollution: a systematic literature review

Conceptualizing the socio-cultural impacts of marine plastic pollution on human well-being - A perspective

Insights from international environmental legislation and protocols for the global plastic treaty

Porocarcinoma in a Patient with Chronic Arsenism and Multiple Bowen's Disease: Case Report

Plastic pollutions in the ocean: their sources, causes, effects and control measures

The global threat from plastic pollution

A growing crisis for One Health: Impacts of plastic pollution across layers of biological function

Solutions and Integrated Strategies for the Control and Mitigation of Plastic and Microplastic Pollution

Transforming the Global Plastics Economy: The Role of Economic Policies in the Global Governance of Plastic Pollution

Plastic pollution and health metrics in wild juvenile green sea turtles (Chelonia mydas) from two Ecuadorian national parks: Galápagos and Machalilla